James Choi

ORCID: 0000-0002-3144-5817
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Reconstructive Surgery and Microvascular Techniques
  • Obstructive Sleep Apnea Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Tracheal and airway disorders
  • Cardiac Structural Anomalies and Repair
  • Cardiac Arrest and Resuscitation
  • Cerebrovascular and Carotid Artery Diseases
  • Oropharyngeal Anatomy and Pathologies
  • Cardiac Imaging and Diagnostics
  • Folate and B Vitamins Research
  • Lysosomal Storage Disorders Research
  • Atrial Fibrillation Management and Outcomes
  • Cleft Lip and Palate Research
  • Oral and Maxillofacial Pathology
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Medical Imaging and Analysis
  • Heart Failure Treatment and Management
  • Airway Management and Intubation Techniques
  • Mechanical Circulatory Support Devices
  • Sarcoidosis and Beryllium Toxicity Research
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Disease and Adiposity
  • Bariatric Surgery and Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Reconstructive Facial Surgery Techniques

Icahn School of Medicine at Mount Sinai
2023-2024

Mount Sinai Hospital
2023

University of Pennsylvania
2012-2020

NYU Langone Health
2020

Hospital of the University of Pennsylvania
2016

Philadelphia University
2016

Cardiac sarcoidosis (CS) is a rare entity characterized by granulomatous infiltration of the myocardium, which can lead to myocardial fibrosis, conduction abnormalities, and development heart failure, thereby elevating risk sudden cardiac death (SCD). While endomyocardial biopsy (EMBx) regarded as gold standard for diagnosis, its low sensitivity inherent procedural risks may limit practical application.

10.3390/jcm13237335 article EN Journal of Clinical Medicine 2024-12-02

Direct oral anticoagulants (DOACs) have catalyzed a significant paradigm shift in the landscape of anticoagulant therapy, emerging as pivotal agents for prevention stroke atrial fibrillation and venous thromboembolism. Although absolute advantages DOACs over vitamin K antagonists (VKAs) may appear modest, clinical guidelines advocate their preference across various indications, attributing this endorsement to ease administration heightened safety. find application preventing treating diverse...

10.1097/crd.0000000000000618 article EN Cardiology in Review 2023-09-27

Recent studies show that patients without standard modifiable risk factors (SMuRF-less) have poorer outcomes in acute myocardial infarction (AMI). This study explores the of post-myocardial complications this subset patients, which has not yet been studied. is a retrospective using National Inpatient Sample for hospitalizations between 2017 - 2019. ICD-10 codes identified presenting with AMI divided into those and SMuRFs (diabetes mellitus, hyperlipidemia, hypertension, smoking). The...

10.1016/j.jscai.2024.101436 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

We present a case of 69-year-old woman with multiple complicating comorbidities who developed medication-related osteonecrosis the jaw secondary to extraction teeth history intravenous bisphosphonate therapy for metastatic breast cancer requiring staged management segmental mandibulectomy placement external pin fixator subsequent exchange this device titanium reconstruction plate and submental island pedicled flap soft tissue coverage bridging plate. Once surgical sites were well-healed that...

10.1177/2472751220966423 article EN Craniomaxillofacial Trauma & Reconstruction Open 2020-01-01

Introduction: Fabry disease, a lysosomal storage disease consisting of an alpha-galactosidase-A deficiency, is associated with multi-organ including the liver, kidneys, and heart. New enzyme replacement gene therapies have emerged in recent years to treat disease. Hypothesis: We aim study temporal trends cardiovascular outcomes hospitalized patients Methods: Using National Inpatient Sample (NIS) database we collected major adverse events (MACE) arrhythmias, acute myocardial injury, stroke,...

10.1161/circ.148.suppl_1.15969 article EN Circulation 2023-11-07
Coming Soon ...